| Nasdaq: ALQA
Alliqua, Inc. is a biomedical company, which develops, manufactures and markets high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The company through subsidiaries develops active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform of AquaMed Technologies, Inc., the company's subsidiary. It manufactures custom hydrogels used for transdermal drug delivery, wound care, medical diagnostics, and cosmetics. HepaLife Biosystems, Inc., focuses on the development of a cell-based bioartificial liver system, known as HepaMate. Alliqua was founded on October 21, 1997 and is headquartered in Langhorne, PA.